Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 0 · FY2023 560 · FY2024 2,200 — 3-yr total 2,760
Georgian distribution arm of Berlin-Chemie/Menarini, the Italian-German pharmaceutical group, marketing its prescription medicines locally.
Subsidiary of Shezghuduli Pasukhismgeblobis Sazogadoeba Berlin Hemi 72445 Distribushens (100.0%)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 464 | 4,453 | 1,226 | 39 | 1,669 | 951 | 595 | nmf |
| Net Cash used in Investing Activities | 1,493 | 106 | 330 | 81 | 89 | 59 | 112 | -35.1% |
| Free Cash Flow (OCF − Capex proxy) | 1,957 | 4,347 | 896 | 42 | 1,758 | 892 | 483 | nmf |
| Net Cash from Financing Activities | 2,213 | 2,102 | 0 | 0 | 0 | 560 | 2,200 | nmf |
| Net Change in Cash (before FX) | 256 | 2,245 | 896 | 42 | 1,758 | 332 | 1,717 | nmf |
| Effect of FX on Cash | 169 | 514 | 236 | 559 | 141 | 87 | 453 | nmf |
| Net Change in Cash (incl. FX) | 87 | 1,731 | 1,132 | 517 | 1,899 | 245 | 1,264 | nmf |
| Cash at Beginning of Year | 0 | 87 | 1,818 | 686 | 169 | 2,068 | 2,313 | +92.7% |
| Cash at End of Year | 87 | 1,818 | 686 | 169 | 2,068 | 2,313 | 1,049 | +51.4% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set.